Furthermore, altered levels of interleukin (IL)-10, IL-1β, IL-4, and IL-2 were reported in the MCI stage of dementia with Lewy bodies (DLB) and MCI-AD, thus supporting the role of the peripheral immune system early in the disease process [30]. The gene discussed is IL2; the disease is Lewy body dementia.